383 related articles for article (PubMed ID: 36870972)
1. Classical monocyte-derived macrophages as therapeutic targets of umbilical cord mesenchymal stem cells: comparison of intratracheal and intravenous administration in a mouse model of pulmonary fibrosis.
Choi SM; Mo Y; Bang JY; Ko YG; Ahn YH; Kim HY; Koh J; Yim JJ; Kang HR
Respir Res; 2023 Mar; 24(1):68. PubMed ID: 36870972
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal Stem Cells Attenuate Asthmatic Inflammation and Airway Remodeling by Modulating Macrophages/Monocytes in the IL-13-Overexpressing Mouse Model.
Mo Y; Kim Y; Bang JY; Jung J; Lee CG; Elias JA; Kang HR
Immune Netw; 2022 Oct; 22(5):e40. PubMed ID: 36381962
[TBL] [Abstract][Full Text] [Related]
3. Nicotinamide phosphoribosyltransferase prompts bleomycin-induced pulmonary fibrosis by driving macrophage M2 polarization in mice.
Chen Y; Wang T; Liang F; Han J; Lou Z; Yu Y; Li J; Zhan T; Gu Y; Dong L; Jiang B; Zhang W; Wu M; Lu Y
Theranostics; 2024; 14(7):2794-2815. PubMed ID: 38773984
[No Abstract] [Full Text] [Related]
4. Adipose-derived mesenchymal stem cell therapy for reverse bleomycin-induced experimental pulmonary fibrosis.
Zhao X; Wu J; Yuan R; Li Y; Yang Q; Wu B; Zhai X; Wang J; Magalon J; Sabatier F; Daumas A; Zhu WM; Zhu N
Sci Rep; 2023 Aug; 13(1):13183. PubMed ID: 37580529
[TBL] [Abstract][Full Text] [Related]
5. M2 macrophages promote myofibroblast differentiation of LR-MSCs and are associated with pulmonary fibrogenesis.
Hou J; Shi J; Chen L; Lv Z; Chen X; Cao H; Xiang Z; Han X
Cell Commun Signal; 2018 Nov; 16(1):89. PubMed ID: 30470231
[TBL] [Abstract][Full Text] [Related]
6. Icariside II modulates pulmonary fibrosis via PI3K/Akt/β-catenin pathway inhibition of M2 macrophage program.
Deng L; Ouyang B; Tang W; Wang N; Yang F; Shi H; Zhang Z; Yu H; Chen M; Wei Y; Dong J
Phytomedicine; 2024 Jul; 130():155687. PubMed ID: 38759312
[TBL] [Abstract][Full Text] [Related]
7. Human bone marrow-derived mesenchymal stromal cells cultured in serum-free media demonstrate enhanced antifibrotic abilities via prolonged survival and robust regulatory T cell induction in murine bleomycin-induced pulmonary fibrosis.
Takao S; Nakashima T; Masuda T; Namba M; Sakamoto S; Yamaguchi K; Horimasu Y; Miyamoto S; Iwamoto H; Fujitaka K; Hamada H; Takahashi S; Nakashima A; Hattori N
Stem Cell Res Ther; 2021 Sep; 12(1):506. PubMed ID: 34530920
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stromal cell exosomes prevent and revert experimental pulmonary fibrosis through modulation of monocyte phenotypes.
Mansouri N; Willis GR; Fernandez-Gonzalez A; Reis M; Nassiri S; Mitsialis SA; Kourembanas S
JCI Insight; 2019 Nov; 4(21):. PubMed ID: 31581150
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary fibrosis model of mice induced by different administration methods of bleomycin.
Gul A; Yang F; Xie C; Du W; Mohammadtursun N; Wang B; Le J; Dong J
BMC Pulm Med; 2023 Mar; 23(1):91. PubMed ID: 36944966
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal Stem Cells-derived Exosomes Ameliorate Lupus by Inducing M2 Macrophage Polarization and Regulatory T Cell Expansion in MRL/lpr Mice.
Sun W; Yan S; Yang C; Yang J; Wang H; Li C; Zhang L; Zhao L; Zhang J; Cheng M; Li X; Xu D
Immunol Invest; 2022 Aug; 51(6):1785-1803. PubMed ID: 35332841
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-preconditioned mesenchymal stem cells attenuate bleomycin-induced pulmonary fibrosis.
Lan YW; Choo KB; Chen CM; Hung TH; Chen YB; Hsieh CH; Kuo HP; Chong KY
Stem Cell Res Ther; 2015 May; 6(1):97. PubMed ID: 25986930
[TBL] [Abstract][Full Text] [Related]
12. TREM2 Insufficiency Protects against Pulmonary Fibrosis by Inhibiting M2 Macrophage Polarization.
Luo Q; Deng D; Li Y; Shi H; Zhao J; Qian Q; Wang W; Cai J; Yu W; Liu J
Int Immunopharmacol; 2023 May; 118():110070. PubMed ID: 37003186
[TBL] [Abstract][Full Text] [Related]
13. The Anti-fibrotic and Anti-inflammatory Potential of Bone Marrow-Derived Mesenchymal Stem Cells and Nintedanib in Bleomycin-Induced Lung Fibrosis in Rats.
Gad ES; Salama AAA; El-Shafie MF; Arafa HMM; Abdelsalam RM; Khattab M
Inflammation; 2020 Feb; 43(1):123-134. PubMed ID: 31646446
[TBL] [Abstract][Full Text] [Related]
14. Urine-Derived Stem Cells Reverse Bleomycin‑Induced Experimental Pulmonary Fibrosis by Inhibition of the TGF-β1-Smad2/3 Pathway.
Zhang Y; Xia Y; Zhang R; Zhou X; Jiang J
Cytotherapy; 2024 May; ():. PubMed ID: 38852093
[TBL] [Abstract][Full Text] [Related]
15. Involvement of necroptotic cell death in macrophages in progression of bleomycin and LPS-induced acute exacerbation of idiopathic pulmonary fibrosis.
Koike A; Hayashi K; Fujimori K
Eur J Pharmacol; 2024 Jun; 972():176572. PubMed ID: 38614381
[TBL] [Abstract][Full Text] [Related]
16. Surfactant protein-D regulates effector cell function and fibrotic lung remodeling in response to bleomycin injury.
Aono Y; Ledford JG; Mukherjee S; Ogawa H; Nishioka Y; Sone S; Beers MF; Noble PW; Wright JR
Am J Respir Crit Care Med; 2012 Mar; 185(5):525-36. PubMed ID: 22198976
[TBL] [Abstract][Full Text] [Related]
17. Hepatocyte Growth Factor Is Required for Mesenchymal Stromal Cell Protection Against Bleomycin-Induced Pulmonary Fibrosis.
Cahill EF; Kennelly H; Carty F; Mahon BP; English K
Stem Cells Transl Med; 2016 Oct; 5(10):1307-1318. PubMed ID: 27388243
[TBL] [Abstract][Full Text] [Related]
18. [Effects of antisense oligonucleotide to nuclear factor-kappaB on the development of bleomycin-induced pulmonary fibrosis and IL-4 expression therein: experiment with mice].
Zhang XY; Zhou Y; Liu WQ; Zhao L; Li SQ
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):195-9. PubMed ID: 17425852
[TBL] [Abstract][Full Text] [Related]
19. Targeting pathogenic macrophages by the application of SHP-1 agonists reduces inflammation and alleviates pulmonary fibrosis.
Hong SY; Lu YT; Chen SY; Hsu CF; Lu YC; Wang CY; Huang KL
Cell Death Dis; 2023 Jun; 14(6):352. PubMed ID: 37291088
[TBL] [Abstract][Full Text] [Related]
20. Effect of intravenous transplantation of hUCB-MSCs on M1/M2 subtype conversion in monocyte/macrophages of AMI mice.
Peng Y; Chen B; Zhao J; Peng Z; Xu W; Yu G
Biomed Pharmacother; 2019 Mar; 111():624-630. PubMed ID: 30611986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
